A 26‐Year‐Old Man With Systemic Lupus Erythematosus, Disseminated Tuberculosis, and Progressive Right Hemiparesis

Documenti analoghi

• Toward Optimal Dosing in Systemic Lupus Erythematosus: The Case for Hydroxychloroquine Blood Level Monitoring
  di: Stephen Balevic, et al.
  Pubblicazione: (2026)
• Clinical Significance of Therapeutic Drug Level Monitoring for Mycophenolate in Patients With Extrarenal Systemic Lupus Erythematosus—A Systematic Review and Meta‐Analysis
  di: Zahraa Qamhieh, et al.
  Pubblicazione: (2026)
• Genetics of Childhood‐Onset Systemic Lupus Erythematosus
  di: Raffaella Carlomagno, et al.
  Pubblicazione: (2025)
• Development of the American College of Rheumatology Patient‐Reported Outcome Quality Measures for Systemic Lupus Erythematosus
  di: Patricia P. Katz, et al.
  Pubblicazione: (2024)
• A Pragmatic Trial of a Shared Decision‐Making Intervention to Improve Medication Adherence and Outcomes in Systemic Lupus Erythematosus: The HCQ ‐ SAFE Study
  di: Caroline Packee, et al.
  Pubblicazione: (2026)